Surgery Partners, Inc.SGRYNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+16.6%
5Y CAGR+14.0%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+16.6%/yr
vs +22.0%/yr prior
5Y CAGR
+14.0%/yr
Consistent
Acceleration
-5.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 28.73% | +78.5% |
| 2024 | 16.10% | -1.0% |
| 2023 | 16.26% | -10.2% |
| 2022 | 18.12% | +0.5% |
| 2021 | 18.02% | +20.7% |
| 2020 | 14.93% | -11.8% |
| 2019 | 16.93% | +107.3% |
| 2018 | 8.17% | -56.5% |
| 2017 | 18.78% | -12.3% |
| 2016 | 21.41% | - |